Skip to content
  • (+359) 2 9156 100
  • Bulgarian
  • English
  • Macedonian
BorolaBorola
  • Home
  • About us
    • Certificates
  • Products
    • Nutraceuticals
      • Products A-Z
      • Antioxidants & Vitamins
      • Gastroenterology
      • Dermatology
      • Child Health
      • Endocrinology
      • Women’s Health
      • Immunology
      • Cardiovascular
      • Men’s Health
      • Neurology
      • Oncology
      • Bone Health
      • Urology
      • Weight management
      • Eye Health
      • Dental Health
      • Urology
      • Ear, Nose & Throat
    • Cosmetic line
      • GinGira® Activ Spray 30 ml
      • GinGira® Alba Bebe Spray 100 ml
      • GinGira® Alba Bebe Spray 30 ml
      • GinGira® Alba Spray 100 ml
      • GinGira® Alba Spray 50 ml
      • GinGira® Medicasol Spray 30 ml
      • Lipobase® cream 100ml
      • Nanobase® cream 30ml
    • Pharmaceuticals
      • Lamisil® 1% Cream (15 g & 30 g)
      • Lamisil® Cutaneous spray 1%
      • Doloproct® 1 mg/40 mg, suppositories
      • Doloproct® 1 mg/g +20 mg/g, rectal cream
      • GYNO-PEVARYL® 50 mg pessaries
      • GYNO-PEVARYL® 150 mg pessaries
      • Medicinal safety
    • Medical devices
      • Lactobor® Intim
  • Services
    • Regulatory
    • Marketing
    • Distribution
    • Clinical
      • Borola Clinic
      • Health Programs
      • Occupational Health
      • Clinical Trials
    • Packaging
  • News
  • Contacts
Clinical Trials

NIBA Research, a subsidiary of BOROLA, is a full-service clinical reseach organization (CRO). We assist our clients with regulatory, medical, monitoring, safety surveillance, project management, quality assurance, drug handling, clinical laboratory and others services.

Our team is comprised of highly qualified experts with diverse clinical trial experience. We offer our clinical research services in most Eastern European countries through our affiliate companies, local investigators and strategic alliances. Our clients are leading pharmaceutical, biotechnology, medical devices, cosmetics and nutraceutical companies.

For more information, please visit our website: www.niba.bg

Borola LTD

Address:z.k. Ovcha Kupel 2, Block 2A, Ground Floor, Sofia 1632
Tel.: (+359) 2 9156 100
Fax: (+359) 2 9156 111
E-mail: office@borola.com

Products
  • Nutraceuticals
  • Cosmetic line GinGira
  • Pharmaceuticals
  • Medical devices
  • Other products
Services
  • Regulatory
  • Marketing
  • Distribution
  • Clinical
  • Packaging
Important Links
  • Online shop
  • Borola Clinic
  • Cosmetics GinGira
  • Clinical trial
  • Care for psoriatic patients
Copyright © 2025 Borola | All rights reserved.
Web design and SEO by Tribest
  • Products
  • Home
  • About us
    • Certificates
  • Products
    • Nutraceuticals
      • Products A-Z
      • Antioxidants & Vitamins
      • Gastroenterology
      • Dermatology
      • Child Health
      • Endocrinology
      • Women’s Health
      • Immunology
      • Cardiovascular
      • Men’s Health
      • Neurology
      • Oncology
      • Bone Health
      • Urology
      • Weight management
      • Eye Health
      • Dental Health
      • Urology
      • Ear, Nose & Throat
    • Cosmetic line
      • GinGira® Activ Spray 30 ml
      • GinGira® Alba Bebe Spray 100 ml
      • GinGira® Alba Bebe Spray 30 ml
      • GinGira® Alba Spray 100 ml
      • GinGira® Alba Spray 50 ml
      • GinGira® Medicasol Spray 30 ml
      • Lipobase® cream 100ml
      • Nanobase® cream 30ml
    • Pharmaceuticals
      • Lamisil® 1% Cream (15 g & 30 g)
      • Lamisil® Cutaneous spray 1%
      • Doloproct® 1 mg/40 mg, suppositories
      • Doloproct® 1 mg/g +20 mg/g, rectal cream
      • GYNO-PEVARYL® 50 mg pessaries
      • GYNO-PEVARYL® 150 mg pessaries
      • Medicinal safety
    • Medical devices
      • Lactobor® Intim
  • Services
    • Regulatory
    • Marketing
    • Distribution
    • Clinical
      • Borola Clinic
      • Health Programs
      • Occupational Health
      • Clinical Trials
    • Packaging
  • News
  • Contacts
  • Bulgarian
  • English
  • Macedonian